Myriad Genetics Inc - ESG Rating & Company Profile powered by AI
Full Sustainability assessment of Myriad Genetics Inc can be reached by signing up for free. If you are employed by Myriad Genetics Inc and you wish to use your Sustainability rating, please get in touch. The webpage contains a Q&A table on Myriad Genetics Inc.
Myriad Genetics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.3; made up of an environmental score of 4.0, social score of 6.9 and governance score of 8.0.
6.3
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
402 | United Laboratories International Holdings Ltd | 6.4 | High |
402 | Zenabis Global Inc | 6.4 | High |
427 | Myriad Genetics Inc | 6.3 | High |
427 | Calliditas Therapeutics AB | 6.3 | High |
427 | Carna Biosciences Inc | 6.3 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Myriad Genetics Inc have an accelerator or VC vehicle to help deliver innovation?
Does Myriad Genetics Inc disclose current and historical energy intensity?
Does Myriad Genetics Inc report the average age of the workforce?
Does Myriad Genetics Inc reference operational or capital allocation in relation to climate change?
Does Myriad Genetics Inc disclose its ethnicity pay gap?
Does Myriad Genetics Inc disclose cybersecurity risks?
Does Myriad Genetics Inc offer flexible work?
Does Myriad Genetics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Myriad Genetics Inc disclose the number of employees in R&D functions?
Does Myriad Genetics Inc conduct supply chain audits?
Does Myriad Genetics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Myriad Genetics Inc conduct 360 degree staff reviews?
Does Myriad Genetics Inc disclose the individual responsible for D&I?
Does Myriad Genetics Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Myriad Genetics Inc disclose current and / or historical scope 2 emissions?
Does Myriad Genetics Inc disclose water use targets?
Does Myriad Genetics Inc have careers partnerships with academic institutions?
Did Myriad Genetics Inc have a product recall in the last two years?
Does Myriad Genetics Inc disclose incidents of discrimination?
Does Myriad Genetics Inc allow for Work Councils/Collective Agreements to be formed?
Has Myriad Genetics Inc issued a profit warning in the past 24 months?
Does Myriad Genetics Inc disclose parental leave metrics?
Does Myriad Genetics Inc disclose climate scenario or pathway analysis?
Does Myriad Genetics Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Myriad Genetics Inc disclose the pay ratio of women to men?
Does Myriad Genetics Inc support suppliers with sustainability related research and development?
Does Myriad Genetics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Myriad Genetics Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Myriad Genetics Inc involved in embryonic stem cell research?
Does Myriad Genetics Inc disclose GHG and Air Emissions intensity?
Does Myriad Genetics Inc disclose its waste policy?
Does Myriad Genetics Inc report according to TCFD requirements?
Does Myriad Genetics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Myriad Genetics Inc disclose energy use targets?
Does Myriad Genetics Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Myriad Genetics Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Myriad Genetics Inc
These potential risks are based on the size, segment and geographies of the company.
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing the risks for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic Test, a DNA sequencing test to help determine the therapy for patients with metastatic breast, ovarian, metastatic pancreatic, or metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic Test, a tumor test that determines homologous recombination deficiency status in patients with ovarian cancer. The company also offers Prolaris Prostate Cancer Prognostic Test, a RNA expression tumor analysis for assessing the aggressiveness of prostate cancer; EndoPredict Breast Cancer Prognostic Test, a RNA expression test for assessing the aggressiveness of breast cancer; Precise Tumor, a solution for precision oncology; and Prequel Prenatal Screen, a non-invasive prenatal screening test conducted using maternal blood to screen for severe chromosomal disorders in a fetus. In addition, it provides Foresight Carrier Screen, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; and GeneSight Psychotropic Mental Health Medication Test, a DNA genotyping test to aid psychotropic drug selection for patients suffering from depression, anxiety, ADHD, and other mental health conditions. Myriad Genetics, Inc. has a strategic collaboration with Illumina, Inc. and Intermountain Precision Genomics for an offering of germline and somatic tumor testing services. The company was founded in 1991 and is headquartered in Salt Lake City, Utah.